These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25727645)

  • 1. The Royal College of Radiologists' audit of prostate brachytherapy in the year 2012.
    Stewart AJ; Drinkwater KJ; Laing RW; Nobes JP; Locke I
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):330-6. PubMed ID: 25727645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Dose and Quality Assurance in Early Prostate Cancer Treated with Low Dose Rate Brachytherapy as Monotherapy.
    Henry AM; Rodda SL; Mason M; Musunuru H; Al-Qaisieh B; Bownes P; Smith J; Franks K; Carey B; Bottomley D
    Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):382-6. PubMed ID: 25805312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Royal College of Radiologists National Vulvar Cancer Audit.
    Baird P; Drinkwater K; Forrest J; Stewart AJ
    Clin Oncol (R Coll Radiol); 2024 Jul; 36(7):e224-e234. PubMed ID: 38658266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report on the early efficacy and tolerability of I(125) permanent prostate brachytherapy from a UK multi-institutional database.
    Mitchell DM; Mandall P; Bottomley D; Hoskin PJ; Logue JP; Ash D; Ostler P; Elliott T; Henry A; Wylie JP
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):738-44. PubMed ID: 18951769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australasian brachytherapy audit: results of the 'end-to-end' dosimetry pilot study.
    Haworth A; Wilfert L; Butler D; Ebert MA; Todd S; Bucci J; Duchesne GM; Joseph D; Kron T
    J Med Imaging Radiat Oncol; 2013 Aug; 57(4):490-8. PubMed ID: 23870350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of image-guided brachytherapy for cervix cancer in the UK: progress update.
    Tan LT
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):681-4. PubMed ID: 21843928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer.
    Bittner NH; Orio PF; Merrick GS; Prestidge BR; Hartford AC; Rosenthal SA
    Brachytherapy; 2017; 16(1):59-67. PubMed ID: 28109632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.
    Clark CH; Aird EG; Bolton S; Miles EA; Nisbet A; Snaith JA; Thomas RA; Venables K; Thwaites DI
    Br J Radiol; 2015; 88(1055):20150251. PubMed ID: 26329469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
    Crook JM; Potters L; Stock RG; Zelefsky MJ
    Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy.
    Yamada Y; Rogers L; Demanes DJ; Morton G; Prestidge BR; Pouliot J; Cohen GN; Zaider M; Ghilezan M; Hsu IC;
    Brachytherapy; 2012; 11(1):20-32. PubMed ID: 22265435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 update.
    Buyyounouski MK; Davis BJ; Prestidge BR; Shanahan TG; Stock RG; Grimm PD; Demanes DJ; Zaider M; Horwitz EM
    Brachytherapy; 2012; 11(4):299-305. PubMed ID: 22330104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a TLD mailed system for remote dosimetry audit for (192)Ir HDR and PDR sources.
    Roué A; Venselaar JL; Ferreira IH; Bridier A; Van Dam J
    Radiother Oncol; 2007 Apr; 83(1):86-93. PubMed ID: 17368842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- and post-implant dosimetry: an inter-comparison between UK prostate brachytherapy centres.
    Al-Qaisieh B;
    Radiother Oncol; 2003 Feb; 66(2):181-3. PubMed ID: 12648790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.
    Davis BJ; Horwitz EM; Lee WR; Crook JM; Stock RG; Merrick GS; Butler WM; Grimm PD; Stone NN; Potters L; Zietman AL; Zelefsky MJ;
    Brachytherapy; 2012; 11(1):6-19. PubMed ID: 22265434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dosimetric standards of USA and France for HDR brachytherapy.
    Douysset G; Gouriou J; Delaunay F; DeWerd L; Stump K; Micka J; ;
    Phys Med Biol; 2005 May; 50(9):1961-78. PubMed ID: 15843730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy.
    Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution.
    Rutten TP; Lawson JM; Marcu LG
    Phys Med; 2013 Nov; 29(6):662-9. PubMed ID: 22975428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103.
    Rivard MJ; Butler WM; Devlin PM; Hayes JK; Hearn RA; Lief EP; Meigooni AS; Merrick GS; Williamson JF
    Brachytherapy; 2007; 6(1):34-7. PubMed ID: 17284383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
    Vicini FA; Kestin LL; Martinez AA
    Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.